home / stock / biib / biib articles

BIIB Articles, Biogen Inc. - From 01/12/24

Stock Information
Company Name: Biogen Inc.
Stock Symbol: BIIB
Market: NASDAQ
Website: biogen.com
Menu
BIIB BIIB Quote BIIB Short BIIB News BIIB Articles BIIB Message Board
Get BIIB Alerts

News, Short Squeeze, Breakout and More Instantly...
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns | Benzinga

A new era in Alzheimer’s diagnosis is on the horizon as Dr. Suzanne Schindler and her team at Washington University School of Medic...
$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,100 Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 2.08% on an annualized basis producing an average annual return of 9.48%...

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments | Benzinga

Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consens...

Comparing Biogen With Industry Competitors In Biotechnology Industry | Benzinga

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this artic...
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 | Benzinga

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...

Understanding Biogen's Position In Biotechnology Industry Compared To Competitors | Benzinga

In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this artic...

If You Invested $100 In This Stock 20 Years Ago, You Would Have $800 Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 3.19% on an annualized basis producing an average annual return of 10.72...
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,200 Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 2.89% on an annualized basis producing an average annual return of 10.34...

S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets | Benzinga

The S&P 500 Index has risen by 19% year-to-date, with three weeks remaining in the year and just a five percentage point gap from the all-time ...

Comparative Study: Biogen And Industry Competitors In Biotechnology Industry | Benzinga

In today's rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess c...
Previous 10 Next 10